Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000469379 | SCV000558032 | benign | not provided | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000469379 | SCV001900385 | benign | not provided | 2019-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001274356 | SCV004848995 | likely benign | Primary ciliary dyskinesia | 2015-08-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001274356 | SCV001458415 | benign | Primary ciliary dyskinesia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000469379 | SCV001800102 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701015 | SCV001927024 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701015 | SCV001966300 | benign | not specified | no assertion criteria provided | clinical testing |